While data supporting the limited use of opioids for post-operative pain has been established, a survey of randomly selected oral and maxillofacial surgeons showed that 22% still prescribed more than 20 opioid tablets and 11% prescribed 30 tablets or more, to high-risk, opioid-naive adolescents, opening the door to misuse and/or diversion.
In the first episode of this CMEOCast podcast series on practice guidelines for pain management, expert faculty discuss utilizing a validated tool to assess patients for risk of misuse and diversion of opioids, as well as applying evidence that supports non-opioid management and whether over the counter treatment options can adequately treat post-operative pain.
At the end of this CME/CE activity, participants should be able to apply evidence and guideline recommendations supporting non-opioid pain management to treatment decision-making.
The following learning objectives pertain only to those requesting CNE or CPE credit: Describe evidence and guideline recommendations supporting non-opioid pain management for treatment decision-making.
Supported by an educational grant from Johnson & Johnson, administered by Johnson & Johnson.
Physicians, orthopedic surgeons, physician assistants, nurse practitioners, and pharmacists.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process.
Dr. Gebke has no disclosures to report.
Dr. Mir has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Call us at (877) CME-PROS or (877) 263-7767.